As of early August 2026, the CDC reports 2,465 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained transmission from 2025 outbreaks centered in communities with MMR vaccination coverage well below the 95% herd immunity threshold needed to prevent endemic spread, resulting in 38 new outbreaks and 94% of cases linked to ongoing chains. Recent model consensus and CDC surveillance data highlight importation risks alongside domestic clusters, with weekly case reports and state-level vaccination coverage updates serving as key near-term indicators. Historical patterns show measles' high basic reproduction number (R0 ~12–18) enables rapid escalation when immunity gaps persist, directly informing trader assessments of whether 2026 totals will stabilize or accelerate before year-end resolution.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,824,866 ปริมาณ
$7,824,866 ปริมาณ
Dec 31, 2026
↑4.5k
26%
↑3k
95%
↑3.5k
95%
↑4k
66%
↑5k
20%
↑7.5k
11%
↑10k
5%
↑12.5k
5%
$7,824,866 ปริมาณ
$7,824,866 ปริมาณ
Dec 31, 2026
↑4.5k
$20 ปริมาณ
26%
↑3k
$89,428 ปริมาณ
95%
↑3.5k
$13,330 ปริมาณ
95%
↑4k
$217,490 ปริมาณ
66%
↑5k
$229,577 ปริมาณ
20%
↑7.5k
$184,996 ปริมาณ
11%
↑10k
$6,514,342 ปริมาณ
5%
↑12.5k
$349,917 ปริมาณ
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC reports 2,465 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained transmission from 2025 outbreaks centered in communities with MMR vaccination coverage well below the 95% herd immunity threshold needed to prevent endemic spread, resulting in 38 new outbreaks and 94% of cases linked to ongoing chains. Recent model consensus and CDC surveillance data highlight importation risks alongside domestic clusters, with weekly case reports and state-level vaccination coverage updates serving as key near-term indicators. Historical patterns show measles' high basic reproduction number (R0 ~12–18) enables rapid escalation when immunity gaps persist, directly informing trader assessments of whether 2026 totals will stabilize or accelerate before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Feb 16, 2026, 11:51 AM ET
ปริมาณการซื้อขาย
$7,824,866วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC reports 2,465 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained transmission from 2025 outbreaks centered in communities with MMR vaccination coverage well below the 95% herd immunity threshold needed to prevent endemic spread, resulting in 38 new outbreaks and 94% of cases linked to ongoing chains. Recent model consensus and CDC surveillance data highlight importation risks alongside domestic clusters, with weekly case reports and state-level vaccination coverage updates serving as key near-term indicators. Historical patterns show measles' high basic reproduction number (R0 ~12–18) enables rapid escalation when immunity gaps persist, directly informing trader assessments of whether 2026 totals will stabilize or accelerate before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,824,866วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early August 2026, the CDC reports 2,465 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained transmission from 2025 outbreaks centered in communities with MMR vaccination coverage well below the 95% herd immunity threshold needed to prevent endemic spread, resulting in 38 new outbreaks and 94% of cases linked to ongoing chains. Recent model consensus and CDC surveillance data highlight importation risks alongside domestic clusters, with weekly case reports and state-level vaccination coverage updates serving as key near-term indicators. Historical patterns show measles' high basic reproduction number (R0 ~12–18) enables rapid escalation when immunity gaps persist, directly informing trader assessments of whether 2026 totals will stabilize or accelerate before year-end resolution.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย